Apex Biotechnology Corp.(TW:1733)
NT$28.60+0.05 (+0.18%)
TW:1733
Apex Biotechnology Corp. Revenue
NT$28.60
At close:+0.05 (+0.18%)
Apex Biotechnology Corp. (1733) Revenue
Apex Biotechnology Corp. Revenue
Apex Biotechnology Corp. had a revenue of 470.65M in the quarter ending Jun 30, 2026, with -9.44%. This bring the company's revenue in the last twelve months to 1.87B, Decreased 2.06%. In the fiscal year ending Dec 31, 2025, Apex Biotechnology Corp. had annual revenue of 1.94B with 5.00% growth.
- Revenue (ttm)
- 1.87B
- Revenue Growth
- -5.22%
- P/S Ratio
- 1.47
- Revenue/Employee
- TWD 3,034,176
- Employees
- 641
- Market Cap
- TWD 2.85B
Revenue Chart
Apex Biotechnology Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.94B | 92.70M | 5.00% |
| Dec 31, 2024 | 1.85B | 175.67M | 10.48% |
| Dec 31, 2023 | 1.68B | -567.64M | -25.29% |
| Dec 31, 2022 | 2.24B | 112.52M | 5.28% |
| Dec 31, 2021 | 2.13B | 126.32M | 6.30% |
| Dec 31, 2020 | 2.01B | -193.53M | -8.80% |
| Dec 31, 2019 | 2.20B | 155.25M | 7.60% |
| Dec 31, 2018 | 2.04B | 248.31M | 13.83% |
| Dec 31, 2017 | 1.80B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.